Skip to main content

sofosbuvir

Generic: SOFOSBUVIR·Brand: Epclusa, SOFOSBUVIR, SOVALDI

sofosbuvir: 3 clinical trials tracked.

sofosbuvir evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about sofosbuvir, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 1 study sponsors
Clinical Trial Registry Records (3)

An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in a Phase 3 Randomized, Controlled, Open-label Study

NCT07037277Registry updated 2026-06-29·Phase 3·AVIR
Active, not recruiting

Primary endpoint: Portion of subjects achieving HCV RNA less than the lower limit of quantitation (LLOQ) at week 24

InterventionalRandomizedsingle880 targetStarted 2025-06Completion 2027-0350 sites · Egypt, France, Germany, Greece…Atea Pharmaceuticals, Inc.

Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvir-Ruzasvir Fixed-dose Combination (BEM/RZR FDC) Versus Sofosbuvir-Velpatasvir Fixed-dose Combination (SOF/VEL FDC) in Subjects With Chronic Hepatitis C Virus (HCV) Infection

NCT06868264Registry updated 2025-12-05·Phase 3·AVIR
Active, not recruiting

Primary endpoint: Proportion of subjects achieving HCV RNA less than the lower limit of quantitation (LLOQ) at study week 24.

InterventionalRandomizedsingle880 targetStarted 2025-04Completion 2026-1250 sites · United StatesAtea Pharmaceuticals, Inc.

Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC

NCT02771405Registry updated 2026-04-13·Phase 3
Completed

Primary endpoint: Percentage of Participants With Sustained Virologic Response 12 Weeks After Treatment

Interventionalopen150 enrolledStarted 2016-03Completion 2018-011 site · EgyptNational Hepatology & Tropical Medicine Research Institute